Literature DB >> 24738643

Tetrandrine and caffeine modulated cell cycle and increased glioma cell death via caspase-dependent and caspase-independent apoptosis pathways.

Jin-Cherng Chen1, Juen-Haur Hwang, Wen-Hsuan Chiu, Yin-Ching Chan.   

Abstract

Viability, cell cycle distribution, and expressions of eukaryotic translation initiation factor-2α (eIF-2α), cyclin D1, poly(ADP-ribose) polymerase 1 (PARP-1), and apoptosis-inducing factor (AIF) of RT-2 glioma cells were assayed under treatment of tetrandrine and caffeine for 48 h. The results showed that cell viability decreased significantly under treatment with tetrandrine (5 μM) alone or under combined treatment with tetrandrine (5 μM) and caffeine (0.5 or 1 mM). The ratio of RT-2 cells at sub G1 and G0/G1 stages increased significantly during combined treatment of tetrandrine (5 μM) and caffeine (0.5, 1 mM). The ratio of phospharylated eIF-2α to dephospharylated eIF-2α increased, whereas cyclin D1 decreased significantly under combined treatment of tetrandrine (5 μM) and caffeine (1 mM). The cleaved PARP-1 to PARP-1 ratio was elevated significantly under treatment of 5 μM tetrandrine alone, and combined treatment of 5 μM tetrandrine and caffeine (0.5, 1 mM). The expression levels of AIF increased significantly under treatment of 5 μM tetrandrine alone or 1 mM caffeine alone, and combined treatment of 5 μM tetrandrine and caffeine (0.5, 1 mM). In conclusion, tetrandrine and caffeine could induce glioma cell death possibly via increasing eIF-2α phospharylation, decreasing cyclin-D1 expression, and increasing caspase-dependent and -independent apoptosis pathways.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24738643     DOI: 10.1080/01635581.2014.902974

Source DB:  PubMed          Journal:  Nutr Cancer        ISSN: 0163-5581            Impact factor:   2.900


  8 in total

1.  Coffee provides a natural multitarget pharmacopeia against the hallmarks of cancer.

Authors:  François Gaascht; Mario Dicato; Marc Diederich
Journal:  Genes Nutr       Date:  2015-11-17       Impact factor: 5.523

2.  Caffeine and its rapidly expanding role in the pathogenesis of malignancies.

Authors:  J-L Xu; R Xia
Journal:  Ir J Med Sci       Date:  2014-07-12       Impact factor: 1.568

3.  Tetrandrine triggers an alternative autophagy in DU145 cells.

Authors:  Wei Qiu; Ai-Li Zhang; Ye Tian
Journal:  Oncol Lett       Date:  2017-03-23       Impact factor: 2.967

4.  Effects of Cinnamaldehyde on the Viability and Expression of Chemokine Receptor Genes in Temozolomide-treated Glioma Cells.

Authors:  Jin-Cherng Chen; Pei-Shan Hsieh; Shu-Min Chen; Juen-Haur Hwang
Journal:  In Vivo       Date:  2020 Mar-Apr       Impact factor: 2.155

5.  Akacid medical formulation induces apoptosis in myeloid and lymphatic leukemic cell lines in vitro and in vivo.

Authors:  Hannes Neuwirt; Elisabeth Wabnig; Clemens Feistritzer; Iris E Eder; Christina Salvador; Martin Puhr; Zoran Culig; Petra Massoner; Martin Tiefenthaler; Michael Steurer; Guenther Konwalinka
Journal:  PLoS One       Date:  2015-02-13       Impact factor: 3.240

6.  Effects of caffeine on cell viability and activity of histone deacetylase 1 and histone acetyltransferase in glioma cells.

Authors:  Jin-Cherng Chen; Juen-Haur Hwang
Journal:  Ci Ji Yi Xue Za Zhi       Date:  2016-08-01

Review 7.  Progress on structural modification of Tetrandrine with wide range of pharmacological activities.

Authors:  Liuying Mo; Fan Zhang; Feng Chen; Lei Xia; Yi Huang; Yuemi Mo; Lingqiu Zhang; Daquan Huang; Shunli He; Jiagang Deng; Erwei Hao; Zhengcai Du
Journal:  Front Pharmacol       Date:  2022-08-16       Impact factor: 5.988

8.  Methylxanthines: Potential Therapeutic Agents for Glioblastoma.

Authors:  Daniel Pérez-Pérez; Iannel Reyes-Vidal; Elda Georgina Chávez-Cortez; Julio Sotelo; Roxana Magaña-Maldonado
Journal:  Pharmaceuticals (Basel)       Date:  2019-09-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.